ADMA Biologics
ADMA
ADMA
345 hedge funds and large institutions have $4.08B invested in ADMA Biologics in 2025 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 127 increasing their positions, 111 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
14% more repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 111
8% more funds holding
Funds holding: 319 → 345 (+26)
0.54% more ownership
Funds ownership: 86.29% → 86.83% (+0.54%)
Holders
345
Holding in Top 10
6
Calls
$67.2M
Puts
$16.3M
Top Buyers
| 1 | +$36M | |
| 2 | +$33.2M | |
| 3 | +$31.8M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$31.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$31.2M |
Top Sellers
| 1 | -$68.1M | |
| 2 | -$32.7M | |
| 3 | -$30.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$26.9M |
| 5 |
ACM
Altium Capital Management
New York
|
-$23.9M |
